Ship in Europe, Find out rates!
Flurbiprofen -based mouthwash.
Benactiv Gola is used in the symptomatic treatment of irritative-inflammatory states also associated with pain in the oropharyngeal cavity (eg gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy.
The drug should be taken according to the following doses and methods: 2-3 rinses or gargles a day with 10 ml (1 scoop) of mouthwash diluted in half a glass of water or pure.
Considering the reduced content of active ingredient and its local use, it is unlikely that overdose situations will occur.
Symptoms of overdose may include nausea, vomiting and gastrointestinal irritation. Treatment should include gastric lavage and, if necessary, correction of the serum electrolyte picture. There is no specific antidote for flurbiprofen.
The following undesirable effects have been reported, particularly after administration of formulations for systemic use:
The topical use of the product, especially if prolonged, can give rise to sensitization or local irritation phenomena. The dissolution in the oral cavity of the product in the form of tablets may be accompanied by sensations of heat or tingling in the oropharynx. In such cases, treatment must be interrupted and appropriate therapy instituted if necessary
During the first and second trimester of pregnancy, flurbiprofen should not be administered except in strictly necessary cases. Administration of flurbiprofen is not recommended in nursing mothers
At the recommended doses, when using the product in its various pharmaceutical forms, any swallowing does not cause any harm to the patient, as the dose of flurbiprofen is much lower than that commonly used in systemic treatments. The use of the product, especially if prolonged, can give rise to sensitization phenomena or local irritation; in such cases it is necessary to interrupt the treatment and consult the doctor to establish, if necessary, a suitable therapy. In patients with renal, cardiac or hepatic insufficiency the product should be used with caution. It is advisable not to associate the product with other NSAIDs. Cases of bronchospasm have been reported with flurbiprofen in patients with a history of bronchial asthma.
Flurbiprofen should be administered with caution to patients with a history of peptic ulcer and other gastrointestinal diseases as these conditions may be exacerbated. The risk of gastrointestinal bleeding, ulcer or perforation is higher with increasing flurbiprofen dosage in patients with a history of ulcer, particularly if complicated with haemorrhage and perforation and in the elderly. These patients should start treatment with the lowest available dose. Gastrointestinal bleeding, ulcer or perforation have been reported with all NSAIDs at any time during treatment. These adverse events can be fatal and can occur with or without warning symptoms or with a previous history of serious gastrointestinal events. Patients with a history of gastrointestinal disease, particularly if elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) in the initial stages of treatment. Elderly patients have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal haemorrhage and perforation, which can be fatal. Undesirable effects can be minimized by using the lowest effective dose for the shortest possible duration of treatment needed to control symptoms.
Benactiv Gola Collutorio and Benactiv Gola Spray contain para-hydroxy-benzoates which can cause delayed allergic reactions, such as contact dermatitis; more rarely they can cause immediate reactions, with hives and bronchospasm.
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored.
Warning : do not use the medicine after the expiry date indicated on the package.
100 ml of Benactiv Throat Mouthwash contain:
Flurbiprofen 250 mg
Glycerol, ethyl alcohol, sorbitol 70, hydrogenated castor oil-40-polyoxyethylenate, sodium hydroxide, sodium saccharinate, methyl parahydroxybenzoate, propyl parahydroxybenzoate, mint essence, patent blue V (E 131), purified water.
Destination | Cost | Detail |
---|---|---|
Italy | €5,90 | 24/48 h |
Austria, Belgium, France, Germany, Netherlands, Poland, Czech Republic | € 12* | 3 days |
Denmark,Luxembourg,Portugal,Slovakia,Spain,Hungary | € 16* | 4 days |
Bulgary,Croatia,Estonia,Finland,Greece,Ireland,Lithuania,Romania,Slovenia,Sweden | € 27* | 5 days |
Canada, Switzerland, United Kingdom, USA | € 45 | 7 Days |